Lilly Moves ImClone R&D To NYC Park | August 3, 2009 Issue - Vol. 87 Issue 31 | Chemical & Engineering News
Volume 87 Issue 31 | p. 17 | Concentrates
Issue Date: August 3, 2009

Lilly Moves ImClone R&D To NYC Park

Department: Business
Keywords: Lilly, ImClone, East River Science Park
New York City Mayor Michael Bloomberg (second from right) looks on as Lilly CEO John C. Lechleiter signs a lease.
Credit: Eli Lilly & Co.
8731bcon_leasecxd1_opt
 
New York City Mayor Michael Bloomberg (second from right) looks on as Lilly CEO John C. Lechleiter signs a lease.
Credit: Eli Lilly & Co.

Eli Lilly & Co. has signed on as the first tenant of the Alexandria Center for Science & Technology at East River Science Park, in New York City. Lilly will shift the roughly 125 scientists at its ImClone R&D unit, which it acquired last year for $6.5 billion, to the new location from another Manhattan neighborhood. Lilly expects to add more scientists at the site as ImClone's pipeline of oncology drugs expands.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment